BioWorld MedTech

July 18, 2019

Paragon Biosciences unveils Qlarity Imaging to advance Quantx system

Chicago-based Paragon Biosciences LLC has launched its seventh portfolio company, Qlarity Imaging LLC, which will focus on further developing Quantx, an FDA-cleared, computer-aided breast cancer diagnosis system. Read More

Endotronix enrolls first patient in CE mark trial for pulmonary artery pressure sensor

Casetabs secures $3M for surgical coordination tech

Industry seeks clarity in FDA's draft rule on radiological health regs

To treat or not to treat? Machine learning has answers

Regulatory front

Financings

Daily M&A

Appointments and advancements

Other news to note

Product regulatory actions for July 17, 2019

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...

New mechanism of action identified for QC-6352

BioWorld Science

QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...